Viewing Study NCT02226757


Ignite Creation Date: 2025-12-24 @ 6:36 PM
Ignite Modification Date: 2025-12-29 @ 1:41 PM
Study NCT ID: NCT02226757
Status: UNKNOWN
Last Update Posted: 2014-08-27
First Post: 2014-06-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Paclitaxel-trastuzumab in EGFR-mutated NSCLC Patients
Sponsor: Amsterdam UMC, location VUmc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module